Holista CollTech Ltd (ASX: HCT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Holista CollTech Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $2.79 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 278.80 million
Earnings per share -0.007
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Holista CollTech Ltd (ASX: HCT)
    Latest News

    asx share penalty represented by lots of fingers pointing at disgraced businessman Crown royal commission WA
    Healthcare Shares

    ASIC accuses ASX company of misleading COVID-19 claims

    The chief executive of the WA business allegedly said on a YouTube video that its sanitiser spray can kill the…

    Read more »

    Speculative

    Why the Holista CollTech share price is climbing higher today

    The Holista CollTech Limited (ASX: HCT) share price is bucking the wider market sell-off today after the company announced the…

    Read more »

    Share Market News

    ASX stock of the day: This small-cap ASX wellness share jumped 6% today after it filed a global patent

    The share price of Holista CollTech Limited (ASX: HCT)has leapt 6% today after the company announced it had filed a…

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    ⏸️ Investing

    The Holista Colltech share price soars 170% today

    Holista Colltech Limited (ASX:HCT) announces major scientific breakthrough

    Read more »

    HCT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Holista CollTech Ltd

    Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. Supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. Ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. Food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. Infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from Supplements segment. Geographically, it generates a majority of its revenue from Malaysia.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ross Deloub Non-Executive ChairmanNon-Executive Director Apr 2023
    Mr Deloub has 30 years experience in the finance and corporate sectors. David has held a number of executive positions including Chief Financial Officer at the ASX listed Neptune Marine Services and Executive Director at Patersons Capital Partners, a Perth based boutique advisory firm providing strategic and financial advice to ASX listed companies. David has considerable corporate finance, business development and financial market experience both in Australia the United States and Africa where he has held senior management positions at Alinta Energy Limited , Neptune Marine Services and Alcoa Inc in the US. David currently holds executive Board positions on the ASX listed Stonehorse Energy Limited and Avira Resources Limited. He has previously held a number of non-executive board positions including; Neptune Marine Services Limited, Merah Resources and Minquest Limited.
    Mrs Loren (Ann Jones) Anne King Non-Executive Director Jul 2021
    Mrs Loren King has worked in corporate finance and senior administration roles with ASX listed companies, stockbroking and corporate advisory services for the past 15 years. she has experience in dealing with all aspects of corporate governance and compliance.

    Mr Lai Kwok Kin Non-Executive Director Mar 2024
    Mr Lai is Founder and Managing Director of Singapore-based WeR1 Consultants Pte Ltd which provides counsel for investor relations and crisis communications to companies listed on regional exchanges.
    Mr Jay Richard Stephenson Company Secretary Sep 2021
    -
    Jay Richard Stephenson Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Galen Biomedical Inc 58,514,245 20.99%
    BNP Paribas Nominees Pty Ltd 43,268,209 15.52%
    818 Corporate Pty Ltd 13,196,169 4.73%
    Ms Sarinderjit Kaur 9,675,785 3.47%
    Citicorp Nominees Pty Limited 8,086,707 2.90%
    Mr Robert Gemelli 7,915,016 2.84%
    HSBC Custody Nominees (Australia) Limited(i) 7,829,102 2.81%
    Mr Anthony Robert Ramage 7,000,000 2.51%
    Fairview Holdings Pty Ltd 6,358,570 2.28%
    Bnp Paribas Noms Pty Ltd 6,352,824 2.28%
    123 Home Loans Pty Ltd 6,100,000 2.19%
    Driscoll Future Pty Ltd 3,750,000 1.35%
    Mr Himmat Singh 3,500,000 1.26%
    Chandra Sekaran P Perumal 3,333,333 1.20%
    Perpetual Capital Investments Pty Ltd 3,000,000 1.08%
    Mr Peter Klimis 1,876,029 0.67%
    HSBC Custody Nominees (Australia) Limited(ii) 1,799,994 0.65%
    Neweconomy Com Au Nominees Pty Limited 1,709,938 0.61%
    Neo Health Sdn Bhd 1,610,613 0.58%
    Mr Kok Seng Chen 1,482,459 0.53%

    Profile

    since

    Note